人胎肝细胞悬液输注引起的过敏性休克3例报告

• 作 者: 杨晓琳
• 机 构: 空军郑州医院传染科,
• 出 处: 人民军医
• 发表日期: 1991年11期
• 关键词: 人胎肝细胞悬液 过敏性休克 肝硬变失代偿期 血清胆红素 病人神志 慢性活动性肝炎 肝昏迷 静脉 支链氨基酸 面色苍白

我科在1988年对重症肝炎,慢性活动性肝炎,肝硬变病人,应用人胎肝细胞悬液(FLC)治疗过程中,有3例病人发生了严重过敏性休克,现将其中2例报道如下。例1 男,61岁。于1988年6月13日以肝硬变失代偿期入院。人院后3天并发肝昏迷Ⅱ～Ⅲ度,以FLC 悬液250ml 静脉输入,每日1次,无反应。于6月19日病人神志转清楚,可正确回答问题,病情好转,停用 FLC 悬液。6月28日,病情又加重,血清胆红素(SB)上升到209.56μmol/L,ALT500U

Our department in 1988 for severe hepatitis, chronic active hepatitis, liver cirrhosis patients, the application of human fetal liver cell suspension (FLC) in the course of treatment, there were 3 patients with severe anaphylactic shock, now 2 cases were reported as follows. Example 1 Male, 61 years old. On June 13, 1988 to liver cirrhosis decompensation admission. 3 days after hospitalization complicated by hepatic coma Ⅱ ~ Ⅲ degrees, 250ml intravenous infusion of FLC suspension, 1 day, no response. On June 19, the patient’s consciousness became clear, the correct answer to the question, the patient’s condition improved, and the suspension of the FLC suspension. June 28, the condition was aggravated, serum bilirubin (SB) rose to 209.56μmol / L, ALT500U